Meditative Movements for Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis

Table 2

Subgroup analyses based on various exclusion criteria for FBG.

Subgroup	n	SMDs, mmol/L (95% CI)	I^2 (%)	Heterogeneity, value	interaction
Total sample size					0.87
>60	10	0.84 (0.22, 1.47)	96	<0.00001
≤60	9	0.91 (0.38, 1.44)	76	<0.0001
Duration					0.11
>3 months	5	1.79 (0.30, 3.28)	98	<0.00001
≤3 months	14	0.55 (0.29, 0.80)	65	0.0004
Control type					0.002
Nonexercise	12	1.42 (0.71, 2.13)	93	0.64
Other active exercises	6	0.27 (0.15, 0.38)	0	<0.00001
Intervention type					0.71
Tai Chi/Qigong	5	0.74 (0.16, 1.32)	72	0.007
Yoga	14	0.89 (0.35, 1.44)	95	<0.00001
Region					0.28
Asia	13	1.50 (-0.25, 3.25)	78	<0.00001
Non-Asia	6	0.53 (0.25, 0.80)	97	<0.00001

CIs, confidence intervals; n, number of trials; SMDs, standardized mean differences.